Share on LinkedInShare on LinkedIn

ARTICLE · 29 JULY 2019

The State AG Report Weekly Update July 25, 2019

The NAAG submitted a comment to the FDA, signed by a bipartisan coalition of 37 AGs led by District of Columbia AG Karl Racine and Oklahoma AG Mike Hunter, in response to the FDA's request for comments ...

United StatesStrategy

CANNABIS/MARIJUANA

Bipartisan Coalition of 37 Attorneys General Submits Comment to FDA Regarding Cannabis Products

  • The National Association of Attorneys General ("NAAG") submitted a comment to the U.S. Food and Drug Administration ("FDA"), signed by a bipartisan coalition of 37 AGs led by District of Columbia AG Karl Racine and Oklahoma AG Mike Hunter, in response to the FDA's request for comments on the safety, manufacturing, and sale of products containing cannabis or cannabis-derived compounds.
  • In the comment, the AGs express concerns that companies that manufacture and market products containing cannabis or cannabis-derived compounds are not regulated as stringently as they should be due to the complexity of the products, and that there is a high risk that such products will be improperly tested, labeled, or packaged in ways that put consumers at risk.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from